These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 1493155

  • 1. Glomerular changes in diabetes mellitus.
    Schleicher ED, Olgemöller B.
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):635-40. PubMed ID: 1493155
    [Abstract] [Full Text] [Related]

  • 2. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW, Daha MR, van den Born J, Verhagen NA, Lemkes HH, Bucala R, Berden JH, Zwinderman AH, Bruijn JA, van Es LA, van der Woude FJ.
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A, Schleicher E.
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [Abstract] [Full Text] [Related]

  • 4. Diabetic glomerulosclerosis--immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulphate proteoglycan.
    Woodrow D, Moss J, Shore I, Spiro RG.
    J Pathol; 1992 May; 167(1):49-58. PubMed ID: 1625058
    [Abstract] [Full Text] [Related]

  • 5. Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy.
    Olgemöller B, Schleicher E.
    Clin Investig; 1993 May; 71(5 Suppl):S13-9. PubMed ID: 8518535
    [Abstract] [Full Text] [Related]

  • 6. [Immunohistochemical localization of various components of the basal membrane and interstitial collagen in diabetic nephropathy].
    Nerlich A, Schleicher E.
    Verh Dtsch Ges Pathol; 1989 May; 73():133-8. PubMed ID: 2482599
    [Abstract] [Full Text] [Related]

  • 7. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 8. Microvascular basement membranes in diabetes mellitus.
    Tsilibary EC.
    J Pathol; 2003 Jul 20; 200(4):537-46. PubMed ID: 12845621
    [Abstract] [Full Text] [Related]

  • 9. Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.
    Ceol M, Nerlich A, Baggio B, Anglani F, Sauer U, Schleicher E, Gambaro G.
    Lab Invest; 1996 Feb 20; 74(2):484-95. PubMed ID: 8780166
    [Abstract] [Full Text] [Related]

  • 10. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K, Hara S, Ubara Y, Tanaka S, Nukui I, Shimura H, Ohashi K, Kobayashi T.
    Diabetes Res Clin Pract; 2009 Mar 20; 83(3):295-9. PubMed ID: 19162360
    [Abstract] [Full Text] [Related]

  • 11. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP, Lautenslager GT, Shearman CW.
    Metabolism; 2001 Dec 20; 50(12):1435-40. PubMed ID: 11735089
    [Abstract] [Full Text] [Related]

  • 12. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
    Nerlich A.
    Veroff Pathol; 1995 Dec 20; 145():1-139. PubMed ID: 8638427
    [Abstract] [Full Text] [Related]

  • 13. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease.
    Ziyadeh FN.
    Miner Electrolyte Metab; 1995 Dec 20; 21(4-5):292-302. PubMed ID: 7565478
    [Abstract] [Full Text] [Related]

  • 14. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T, Mima A, Matsubara T, Tominaga T, Arai H, Abe H.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [Abstract] [Full Text] [Related]

  • 15. Constituents of the extracellular matrices in diabetic glomerulosclerosis.
    Suzuki Y.
    Nihon Jinzo Gakkai Shi; 1989 Oct 13; 31(10):1047-54. PubMed ID: 2615016
    [Abstract] [Full Text] [Related]

  • 16. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE.
    Nephrol Dial Transplant; 2008 Apr 13; 23(4):1346-54. PubMed ID: 18065828
    [Abstract] [Full Text] [Related]

  • 17. [Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus].
    Sternberg M, Urios P, Grigorova-Borsos AM.
    C R Seances Soc Biol Fil; 1995 Apr 13; 189(6):967-85. PubMed ID: 8763028
    [Abstract] [Full Text] [Related]

  • 18. Structural and functional changes in diabetic glomerulopathy.
    Schleicher E, Kolm V, Ceol M, Nerlich A.
    Kidney Blood Press Res; 1996 Apr 13; 19(5):305-15. PubMed ID: 8956243
    [Abstract] [Full Text] [Related]

  • 19. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy.
    Viberti G, Keen H.
    Diabetes; 1984 Jul 13; 33(7):686-92. PubMed ID: 6376224
    [No Abstract] [Full Text] [Related]

  • 20. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy.
    Adler S.
    J Am Soc Nephrol; 1994 Nov 13; 5(5):1165-72. PubMed ID: 7873725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.